LUIS
ALOU CERVERA
Profesor ayudante doctor
Universidad Autónoma de Madrid
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Universidad Autónoma de Madrid (9)
2010
-
Exposure-response analysis of tigecycline in pharmacodynamic simulations using different size inocula of target bacteria
International Journal of Antimicrobial Agents, Vol. 36, Núm. 2, pp. 137-144
-
Influence of media and testing methodology on susceptibility to tigecycline of Enterobacteriaceae with reported high tigecycline MIC
Journal of Clinical Microbiology, Vol. 48, Núm. 6, pp. 2243-2246
2009
-
Genotypic versus phenotypic characterization, with respect to β-lactam susceptibility, of Haemophilus influenzae isolates exhibiting decreased susceptibility to β-lactam resistance markers
Antimicrobial Agents and Chemotherapy, Vol. 53, Núm. 1, pp. 267-270
-
In vitro effect of physiological concentrations of human albumin on the antibacterial activity of tigecycline
Journal of Antimicrobial Chemotherapy, Vol. 64, Núm. 6
2008
2005
-
Effect of opsonophagocytosis mediated by specific antibodies on the co-amoxiclav serum bactericidal activity against Streptococcus pneumoniae after administration of a single oral dose of pharmacokinetically enhanced 2000/125 mg co-amoxiclav to healthy volunteers
Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 5, pp. 742-747
2004
-
Bactericidal activity of amoxicillin against non-susceptible Streptococcus pneumoniae in an in vitro pharmacodynamic model simulating the concentrations obtained with the 2000/125 mg sustained-release co-amoxiclav formulation
Journal of Antimicrobial Chemotherapy, Vol. 54, Núm. 6, pp. 1148-1151
2001
-
Influence of diminished susceptibility of Streptococcus pneumoniae to ciprofloxacin on the serum bactericidal activity of gemifloxacin and trovafloxacin after a single dose in healthy volunteers
International Journal of Antimicrobial Agents, Vol. 18, Núm. 3, pp. 231-238
1998
-
Estudio de la actividad bactericida de la combinación amoxicilina/ácido clavulánico y sus posibles efectos ante la resistencia a betalactámicos de Streptococcus pneumoniae
Medicina Clinica, Vol. 110, Núm. SUPPL. 1, pp. 12-15